Affinage

TBC1D9

TBC1 domain family member 9 · UniProt Q6ZT07

Round 2 corrected
Length
1266 aa
Mass
143.2 kDa
Annotated
2026-04-28
130 papers in source corpus 2 papers cited in narrative 2 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

TBC1D9 is a Ca²⁺-sensing, ubiquitin-recognizing TBC domain protein that functions as an upstream activator of TBK1 during selective autophagy. It binds ubiquitin-coated substrates—including intracellular bacteria and damaged mitochondria—through its ubiquitin-binding region (UBR) in a Ca²⁺-dependent manner, and its knockout abolishes TBK1 activation and subsequent ULK1 complex recruitment during both xenophagy and mitophagy (PMID:32034138). TBC1D9 also directly interacts with ATG8/LC3 family proteins via a LIR motif and colocalizes with LC3-positive autophagy membranes, consistent with a role as a selective autophagy adaptor (PMID:22354992).

Mechanistic history

Synthesis pass · year-by-year structured walk · 2 steps
  1. 2012 Medium

    Whether TBC domain-containing Rab GAPs participate in autophagy was unknown; a systematic interaction screen revealed that TBC1D9 directly binds ATG8/LC3 family members and colocalizes with LC3-positive membranes, establishing it as a candidate autophagy-linked adaptor.

    Evidence Pulldown/binding assays with ATG8 modifiers and colocalization imaging in mammalian cells

    PMID:22354992

    Open questions at the time
    • TBC1D9 was one of 14 hits; no functional follow-up specific to TBC1D9 was performed
    • The biological consequence of TBC1D9–LC3 binding was not tested
    • No substrate-targeting or cargo-recognition mechanism was defined
  2. 2020 High

    How TBC1D9 is activated and what downstream signaling it controls were unknown; knockout and domain-mutant analyses demonstrated that Ca²⁺-dependent ubiquitin recognition by TBC1D9 is required for TBK1 activation and ULK1 complex recruitment during both xenophagy and mitophagy, placing TBC1D9 as a Ca²⁺-sensing signal integrator upstream of TBK1.

    Evidence TBC1D9-KO cells, Ca²⁺ chelation, Co-IP with ubiquitin-positive bacteria, immunofluorescence, UBR and Ca²⁺-binding motif mutant analysis across xenophagy and mitophagy contexts

    PMID:32034138

    Open questions at the time
    • Whether TBC1D9 retains or uses Rab GAP catalytic activity during autophagy has not been tested
    • The structural basis of Ca²⁺-dependent ubiquitin recognition is unresolved
    • Contribution of the LIR motif versus the UBR to cargo selectivity has not been dissected in vivo

Open questions

Synthesis pass · forward-looking unresolved questions
  • It remains unknown whether TBC1D9 functions as a bona fide Rab GAP in autophagy signaling, which Rab substrates (if any) it acts on, and how the Ca²⁺-binding, ubiquitin-binding, and LIR-dependent interactions are coordinated to drive selective autophagy.
  • No Rab GAP activity has been demonstrated for TBC1D9
  • No structural model of TBC1D9 exists
  • In vivo relevance in animal models has not been established

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 2
Localization
GO:0031410 cytoplasmic vesicle 2 GO:0005739 mitochondrion 1
Pathway
R-HSA-9612973 Autophagy 2 R-HSA-168256 Immune System 1
Partners

Evidence

Reading pass · 2 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2012 TBC1D9 (and 13 other TBC domain-containing Rab GAPs) was found to directly bind ATG8 family modifiers (LC3/GABARAP) and colocalize with LC3-positive autophagy membranes in cells, identifying it as a candidate autophagy adaptor containing a LIR (LC3-interacting region) motif. Comprehensive protein-protein interaction screen (pulldown/binding assays with ATG8 modifiers) combined with colocalization imaging of LC3-positive membranes Molecular and cellular biology Medium 22354992
2020 TBC1D9 controls TBK1 activation during xenophagy and mitophagy through Ca2+-dependent ubiquitin recognition. Bacterial infection raises intracellular Ca2+ levels, which enables TBC1D9's Ca2+-binding motif and ubiquitin-binding region (UBR) to mediate binding to ubiquitin-coated bacteria. TBC1D9 knockout suppresses TBK1 activation and subsequent recruitment of the ULK1 complex. A Ca2+ chelator impairs TBC1D9–ubiquitin interactions and TBK1 activation. TBC1D9 is also recruited to damaged mitochondria via its UBR and Ca2+-binding motif and is required for TBK1 activation during mitophagy. Knockout cells (TBC1D9 KO), Ca2+ chelation experiments, Co-immunoprecipitation of TBC1D9 with ubiquitin-positive bacteria, immunofluorescence colocalization, ULK1 complex recruitment assays, domain mutant analysis (UBR and Ca2+-binding motif) Nature communications High 32034138

Source papers

Stage 0 corpus · 130 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2006 A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science (New York, N.Y.) 1885 17185560
2002 Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proceedings of the National Academy of Sciences of the United States of America 1479 12477932
2004 Large-scale characterization of HeLa cell nuclear phosphoproteins. Proceedings of the National Academy of Sciences of the United States of America 1159 15302935
2015 The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell 1118 26186194
2017 Architecture of the human interactome defines protein communities and disease networks. Nature 1085 28514442
2015 A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell 1015 26496610
2001 Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clinical pharmacology and therapeutics 836 11503014
2018 VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation. Cell discovery 829 29507755
2002 Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer research 713 12067980
2001 Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. The Journal of biological chemistry 706 11297522
2021 Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 705 33961781
2011 Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Briefings in bioinformatics 656 21873635
2005 Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenetics and genomics 396 16141795
1986 The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochemical and biophysical research communications 386 2880583
1987 The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. The Journal of biological chemistry 359 3027054
2021 A proximity-dependent biotinylation map of a human cell. Nature 339 34079125
2003 Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics 328 12893986
2001 Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 321 11692082
2020 Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis. Med (New York, N.Y.) 291 32838362
2009 A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochimica et biophysica acta 267 19285158
2004 Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nature biotechnology 266 15146197
1990 Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. The Journal of biological chemistry 243 1967175
2002 Genetic polymorphisms of the human MDR1 drug transporter. Annual review of pharmacology and toxicology 238 12359865
2015 Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature. Clinical pharmacokinetics 196 25860377
2003 Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs. Pharmacogenomics 195 12831320
1998 Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA research : an international journal for rapid publication of reports on genes and genomes 190 10048485
2015 CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin. Molecular cancer therapeutics 180 25840583
2011 Protein interactome reveals converging molecular pathways among autism disorders. Science translational medicine 180 21653829
2008 Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells. Molecular cancer therapeutics 167 18347152
1989 P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochemical and biophysical research communications 162 2568832
2005 Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. British journal of clinical pharmacology 157 15963094
2002 MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biological & pharmaceutical bulletin 157 12419946
2012 Rab GTPase-activating proteins in autophagy: regulation of endocytic and autophagy pathways by direct binding to human ATG8 modifiers. Molecular and cellular biology 148 22354992
2008 Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance. PloS one 148 18461144
2004 Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Therapeutic drug monitoring 143 15228162
2000 Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. Proceedings of the National Academy of Sciences of the United States of America 135 10737800
2004 Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes and immunity 131 15505619
2004 The MDR1 (ABCB1) gene polymorphism and its clinical implications. Clinical pharmacokinetics 124 15217301
1990 Expression of the multidrug resistance, MDR1, gene in neuroblastomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 123 2295903
2004 Therapeutic implications of the MDR-1 gene. Journal of veterinary pharmacology and therapeutics 117 15500562
2003 P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation. The Journal of biological chemistry 115 12525496
2010 Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Molecular medicine (Cambridge, Mass.) 108 20379614
2005 MDR1 genotype-related pharmacokinetics: fact or fiction? Drug metabolism and pharmacokinetics 106 16415525
2005 Expression of PXR, CYP3A and MDR1 genes in liver of zebrafish. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 99 15914091
2004 Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner. The American journal of cardiology 94 15081455
2003 Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer. American journal of physiology. Cell physiology 91 12724138
1997 Gene rearrangement: a novel mechanism for MDR-1 gene activation. The Journal of clinical investigation 90 9109439
2017 MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation. Mucosal immunology 88 28401939
2005 Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 88 16355344
1993 Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression. Leukemia 84 8099135
2007 Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells. Biochemical and biophysical research communications 81 17482571
1996 Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate. International journal of cancer 78 8598312
2005 Characterization of the human MDR1 gene. The AAPS journal 75 16146331
2001 Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. The Biochemical journal 74 11463358
2013 MDR1 (ABCB1) polymorphisms: functional effects and clinical implications. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 73 24687344
2003 High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma. Leukemia 73 12970790
2000 Regulation of the MDR1 gene by transcriptional repressors selected using peptide combinatorial libraries. Molecular pharmacology 73 10860921
2022 Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer. Cell death and differentiation 71 35484333
1991 Multidrug resistance gene (MDR1) expression in human brain tumors. Journal of neurosurgery 71 1682428
2019 Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 70 31811017
2016 Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance. Oncotarget 69 27835872
2000 CFTR, MDR1, and MRP1 immunolocalization in normal human nasal respiratory mucosa. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 66 10950878
2008 Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals. Journal of agricultural and food chemistry 63 18540626
1993 Functional expression of mouse mdr1 in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 60 8105473
2007 Inhibition of MDR1 expression with altritol-modified siRNAs. Nucleic acids research 59 17264131
1994 Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants. Oncology research 58 7949467
1992 Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (MDR1) expression caused by arsenite. FEBS letters 56 1349537
2018 MDR1 in immunity: friend or foe? Oncoimmunology 55 30524890
2010 Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance. Cancer research 55 20861184
2010 Breed distribution of the nt230(del4) MDR1 mutation in dogs. Veterinary journal (London, England : 1997) 54 20655253
2006 P-glycoprotein (MDR1) functional activity in human alveolar epithelial cell monolayers. Cell and tissue research 54 17165089
2016 Complete Knockout of Endogenous Mdr1 (Abcb1) in MDCK Cells by CRISPR-Cas9. Journal of pharmaceutical sciences 53 26869442
2006 MDR1 gene polymorphisms and clinical relevance. Yi chuan xue bao = Acta genetica Sinica 53 16529292
1996 A "double adaptor" method for improved shotgun library construction. Analytical biochemistry 53 8619474
1999 Comparative aspects of the function and mechanism of SUR1 and MDR1 proteins. Biochimica et biophysica acta 51 10581363
2018 The UDP-glucose ceramide glycosyltransferase (UGCG) and the link to multidrug resistance protein 1 (MDR1). BMC cancer 50 29409484
2010 Evaluation of biodistribution and safety of adenovirus vector containing MDR1 in mice. Journal of experimental & clinical cancer research : CR 50 20044941
2007 Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) II. Clinical aspects. Drug discovery today 50 17933685
2006 Characterization of gene rearrangements leading to activation of MDR-1. The Journal of biological chemistry 48 16956878
1992 From amplification to function: the case of the MDR1 gene. Mutation research 48 1374511
2018 Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene. Leukemia & lymphoma 46 29616858
2008 Identification and characterization of a novel Tre-2/Bub2/Cdc16 (TBC) protein that possesses Rab3A-GAP activity. Genes to cells : devoted to molecular & cellular mechanisms 46 19077034
2020 TBC1D9 regulates TBK1 activation through Ca2+ signaling in selective autophagy. Nature communications 45 32034138
1997 Large-scale concatenation cDNA sequencing. Genome research 45 9110174
2014 Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR. Toxicology letters 42 25542144
2006 Effect of ABCB1 (MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects. British journal of clinical pharmacology 40 16869811
2005 Drug-induced regulation of the MDR1 promoter in Candida albicans. Antimicrobial agents and chemotherapy 40 15980350
2003 Digoxin up-regulates multidrug resistance transporter (MDR1) mRNA and simultaneously down-regulates steroid xenobiotic receptor mRNA. Biochemical and biophysical research communications 40 12788075
1998 Modulation of MDR1 and CYP3A expression by dexamethasone: evidence for an inverse regulation in adrenals. Biochemical and biophysical research communications 40 9826540
2022 Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris. Antimicrobial agents and chemotherapy 39 35343781
2012 Treatment of MDR1 mutant dogs with macrocyclic lactones. Current pharmaceutical biotechnology 39 22039792
2006 Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression? Planta medica 39 16755466
1997 Drug resistance conferred by MDR1 expression in spheroids formed by glioblastoma cell lines. Anticancer research 38 9413166
2011 Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome. Pediatric nephrology (Berlin, Germany) 37 21553324
2006 Polymorphisms of the MDR1 gene in the Czech population. Folia biologica 37 17184596
2015 HIF-1α/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer. Oncology reports 36 26717965
2005 Significance of cyclooxygenase 2 and MDR1/P-glycoprotein coexpression in ovarian cancers. Cancer letters 35 15970376
2003 Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania. The pharmacogenomics journal 35 14583799
2007 Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells. Biological & pharmaceutical bulletin 34 17541155
2007 DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function. Oncogene 34 17952118
2006 Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study. Progress in neuro-psychopharmacology & biological psychiatry 33 16386826
1999 A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease. Advances in experimental medicine and biology 33 10500782
2007 Impact of ABCB1 (MDR1) gene polymorphism and P-glycoprotein inhibitors on digoxin serum concentration in congestive heart failure patients. Pharmacological reports : PR 32 17377214
2022 CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma. International journal of molecular sciences 31 35955749
2017 Substrate and method dependent inhibition of three ABC-transporters (MDR1, BCRP, and MRP2). European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 30 28263911
2006 Evidence of Oatp and Mdr1 in cryopreserved rat hepatocytes. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 30 17174077
1995 Expression of mdr1/P-glycoprotein and p110 in neuroblastoma. The Journal of pathology 30 7891222
2022 SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis. Communications biology 29 36180527
2016 TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. Molecular & cellular proteomics : MCP 28 27609421
2015 NOX1 mediates chemoresistance via HIF1α/MDR1 pathway in gallbladder cancer. Biochemical and biophysical research communications 28 26545779
2011 MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. Asian Pacific journal of cancer prevention : APJCP 28 22296392
2004 Plasmodium yoelii: identification and partial characterization of an MDR1 gene in an artemisinin-resistant line. The Journal of parasitology 28 15040683
2011 Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients. Renal failure 27 21851199
2004 Clinical relationship between MDR1 gene and gallbladder cancer. Hepatobiliary & pancreatic diseases international : HBPD INT 27 15138130
2015 The roles of variants in human multidrug resistance (MDR1) gene and their haplotypes on antiepileptic drugs response: a meta-analysis of 57 studies. PloS one 26 25816099
2005 Canine mdr1 gene mutation in Japan. The Journal of veterinary medical science 26 16327220
2022 A dual-activity topoisomerase complex regulates mRNA translation and turnover. Nucleic acids research 25 35748872
2022 Combination of polythyleneimine regulating autophagy prodrug and Mdr1 siRNA for tumor multidrug resistance. Journal of nanobiotechnology 25 36369077
2016 MDR1 mediated chemoresistance: BMI1 and TIP60 in action. Biochimica et biophysica acta 25 27295567
2013 Regulation of the MDR1 promoter by E2F1 and EAPP. FEBS letters 25 23542036
2013 The biology of MDR1-P-glycoprotein (MDR1-Pgp) in designing functional antibody drug conjugates (ADCs): the experience of gemtuzumab ozogamicin. Annali dell'Istituto superiore di sanita 25 23771260
2012 CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells. Pharmacological reports : PR 25 22814029
2006 Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease. Scandinavian journal of gastroenterology 25 16990202
2017 MiR-138 indirectly regulates the MDR1 promoter by NF-κB/p65 silencing. Biochemical and biophysical research communications 24 28153721
2006 Genotype and allele frequency of human multidrug resistance (MDR1) gene C3435T polymorphism in Denizli province of Turkey. Molecular biology reports 24 17080296
2002 Caveolin-1 expression in ovarian carcinoma is MDR1 independent. American journal of clinical pathology 23 11863219
1994 Multidrug-resistance gene (mdr1) expression in human tumor xenografts. International journal of oncology 23 21559711
2015 Myotubularin-related proteins 3 and 4 interact with polo-like kinase 1 and centrosomal protein of 55 kDa to ensure proper abscission. Molecular & cellular proteomics : MCP 20 25659891
2008 CD34+ leukemic subpopulation predominantly displays lower spontaneous apoptosis and has higher expression levels of Bcl-2 and MDR1 genes than CD34- cells in childhood AML. Annals of hematology 16 18228020
2023 CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. Cell death and differentiation 9 37468549